Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis
Clinical trial NCT05059509 · COMPLETED
Trial details
- NCT number
- NCT05059509
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-06
- Primary completion
- 2021-05-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.